Health
Report: Moderna Sets Price Range for Coronavirus Vaccine – Motley Fool
If and when mRNA-1273 becomes available, it will apparently be relatively expensive.
Considered by many observers to be the leader in the hunt for a coronavirus vaccine, Moderna(NASDAQ:MRNA) has apparently settled on a price for its potential blockbuster product. Citing “people familiar with talks between the company and potential buyers,” the Financial Times reported Tuesday that the company aims to sell its vaccine at roughly $50 to $60 per two-dose treatment course.
That price applies to relatively prosperous countries such as the U.S. The article quoted “other people famili…
-
General24 hours agoAustralia’s Myanmar community mourns earthquake losses
-
General22 hours agoPeter Dutton partially walks back public service work-from-home vow
-
Noosa News20 hours agoDisaster relief packages announced for flood-stricken western Queensland
-
Noosa News23 hours agoAustralian growers expect to benefit from US tariffs as Trump’s trade war angers markets